These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 30168393)

  • 1. Non-communicable disease prevention policy process in five African countries.
    Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
    BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
    Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of non-communicable diseases policies in post-apartheid South Africa.
    Ndinda C; Ndhlovu TP; Juma P; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):956. PubMed ID: 30168397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncommunicable Disease (NCD) strategic plans in low- and lower-middle income Sub-Saharan Africa: framing and policy response.
    Boudreaux C; Noble C; Coates MM; Kelley J; Abanda M; Kintu A; McLaughlin A; Marx A; Bukhman G
    Glob Health Action; 2020 Dec; 13(1):1805165. PubMed ID: 32873212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two decades of tobacco use prevention and control policies in Cameroon: results from the analysis of non-communicable disease prevention policies in Africa.
    Mapa-Tassou C; Bonono CR; Assah F; Wisdom J; Juma PA; Katte JC; Njoumemi Z; Ongolo-Zogo P; Fezeu LK; Sobngwi E; Mbanya JC
    BMC Public Health; 2018 Aug; 18(Suppl 1):958. PubMed ID: 30168394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of alcohol policy in Nigeria: multi-sectoral action and the integration of the WHO "best-buy" interventions.
    Abiona O; Oluwasanu M; Oladepo O
    BMC Public Health; 2019 Jun; 19(1):810. PubMed ID: 31234812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol policies in Malawi: inclusion of WHO "best buy" interventions and use of multi-sectoral action.
    Matanje Mwagomba BL; Nkhata MJ; Baldacchino A; Wisdom J; Ngwira B
    BMC Public Health; 2018 Aug; 18(Suppl 1):957. PubMed ID: 30168398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responding to non-communicable diseases in Zambia: a policy analysis.
    Mukanu MM; Zulu JM; Mweemba C; Mutale W
    Health Res Policy Syst; 2017 Apr; 15(1):34. PubMed ID: 28438177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
    Allen LN; Wigley S; Holmer H; Barlow P
    Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries.
    Allen LN; Nicholson BD; Yeung BYT; Goiana-da-Silva F
    Lancet Glob Health; 2020 Jan; 8(1):e50-e58. PubMed ID: 31813787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and challenges for evidence-informed HIV-noncommunicable disease integrated care policies and programs: lessons from Malawi, South Africa, Swaziland and Kenya.
    Matanje Mwagomba BL; Ameh S; Bongomin P; Juma PA; MacKenzie RK; Kyobutungi C; Lukhele N; Mwangi KJM; Amberbir A; Klipstein-Grobusch K; Gómez-Olivé FX; Berman J
    AIDS; 2018 Jul; 32 Suppl 1():S21-S32. PubMed ID: 29952787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengthening implementation of diet-related non-communicable disease prevention strategies in Fiji: a qualitative policy landscape analysis.
    Mounsey S; Waqa G; McKenzie B; Reeve E; Webster J; Bell C; Thow AM
    Global Health; 2022 Sep; 18(1):79. PubMed ID: 36050736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis.
    Bertram MY; Chisholm D; Watts R; Waqanivalu T; Prasad V; Varghese C
    Int J Health Policy Manag; 2021 Nov; 10(11):724-733. PubMed ID: 34273918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Non-communicable disease prevention policies in five Sub-Saharan African countries: Study protocol.
    Juma PA; Mohamed SF; Wisdom J; Kyobutungi C; Oti S
    Arch Public Health; 2016; 74():25. PubMed ID: 27335640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the WHO framework convention on tobacco control on tobacco legislation and policies in sub-Saharan Africa.
    Wisdom JP; Juma P; Mwagomba B; Ndinda C; Mapa-Tassou C; Assah F; Nkhata M; Mohamed SF; Oladimeji O; Oladunni O; Oluwasanu M; Sanni S; Mbanya JC; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):954. PubMed ID: 30168395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policies for type 2 diabetes and non-communicable disease management during the COVID-19 pandemic in Kenya and Tanzania: a desk review and views of decision-makers.
    Mohamed SF; Kisia L; Mashiashi I; Mair F; Wisdom JP; Bunn C; Gray C; Kibe PM; Sanya RE; Karugu CH; Mtenga SM; Binyaruka P; Asiki G
    BMJ Open; 2024 Mar; 14(3):e073261. PubMed ID: 38531573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping research evidence on implementation of the WHO 'best buys' and other interventions for the prevention and control of non-communicable diseases in sub-Saharan Africa: a scoping review protocol.
    Kadiri A; Ansu-Mensah M; Bawontuo V; Kuupiel D
    Syst Rev; 2022 Jun; 11(1):120. PubMed ID: 35698207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamic of non-communicable disease control policy in Indonesia.
    Christiani Y; Dugdale P; Tavener M; Byles JE
    Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
    Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
    BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and Opportunities for WHO "Best Buys" Non-communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review.
    Loffreda G; Arakelyan S; Bou-Orm I; Holmer H; Allen LN; Witter S; Ager A; Diaconu K
    Int J Health Policy Manag; 2024; 13():7989. PubMed ID: 38618832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.